Filing Details
- Accession Number:
- 0000897069-23-001091
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-04 13:42:39
- Reporting Period:
- 2023-08-02
- Accepted Time:
- 2023-08-04 13:42:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1904286 | Mira Pharmaceuticals Inc. | MIRA | Pharmaceutical Preparations (2834) | 853354547 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1986372 | George Cappy | C/O Mira Pharmaceuticals, Inc. 900 West Platt Street, Suite 200 Tampa FL 33606-2173 | No | No | No | No | |
1986593 | Trust Shore Bay | C/O Mira Pharmaceuticals, Inc. 900 West Platt Street, Suite 200 Tampa FL 33606-2173 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-08-02 | 157,170 | $7.00 | 2,740,270 | No | 4 | P | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 20,000 | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock Warrant (right to buy) | $5.00 | 2023-04-28 | 2028-04-28 | 1,000,000 | 1,000,000 | Indirect |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2028-04-28 | 1,000,000 | 1,000,000 | Indirect |
Footnotes
- Represents the acquisition of shares of common stock by the Bay Shore Trust (the "Trust") through the conversion of an aggregate of $1,100,190 of indebtedness owing by the Issuer to the Trust, with such conversion occurring on the date of the Issuer's initial public offering at a conversion price of $7.00 per share.
- These securities are owned directly by the Trust, a greater-than-10% owner of the Issuer. As sole trustee of the Trust, George Cappy ("Mr. Cappy") has sole ownership and dispositive power over these securities and is therefore deemed to be an indirect beneficial owner of the securities for purposes of SEC Rule 13d-3, although Mr. Cappy disclaims beneficial ownership of the reported securities due to the absence of any pecuniary interest therein.
- These securities are owned directly by Mr. Cappy.